{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-32141343-dulaglutide:v1","objectPathId":"pubmed-pmid-32141343-dulaglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-32141343-dulaglutide/","json":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-32141343-dulaglutide-v1.json","markdown":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-32141343-dulaglutide-v1.md"},"story":{"slug":"pubmed-pmid-32141343-dulaglutide","version":1,"domain":"Literature metadata","dateInSource":"2021-03-11","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["dulaglutide"],"peptides":[{"slug":"dulaglutide","url":"https://peptidescanner.com/peptides/dulaglutide/"}]},"claims":[{"id":"headline","text":"Comparative study of dulaglutide single-use pen Ateos versus insulin degludec FlexTouch on learning and mock administration time in Japanese patients with type 2 diabetes mellitus - a post-hoc analys…","sourceIds":["pubmed-observation-pmid-32141343-2021-03-11-7452eedf35fd"]},{"id":"summary","text":"PubMed lists PMID 32141343 in Current medical research and opinion as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-03-19 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-32141343-2021-03-11-7452eedf35fd"]},{"id":"paragraph-1","text":"PubMed lists PMID 32141343 in Current medical research and opinion as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-03-19 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-32141343-2021-03-11-7452eedf35fd"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-32141343-2021-03-11-7452eedf35fd"]}],"sources":[{"id":"pubmed-observation-pmid-32141343-2021-03-11-7452eedf35fd","name":"PubMed","sourceClass":"A","title":"Comparative study of dulaglutide single-use pen Ateos versus insulin degludec FlexTouch on learning and mock administration time in Japanese patients with type 2 diabetes mellitus - a post-hoc analysis. · retained source version 1:2021-03-11:current:7452eedf35fdd99847e07c9f4c6dd02073fe2ae10d60fc7c3f739fe290f936b7","url":"https://pubmed.ncbi.nlm.nih.gov/32141343/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"4537a7a1ffd9e7b05dd0c8211007d078c8d6c54af788e4e1d66998a0adc0911e","tierARecordSha256":"296f98cad78f72134c86e17586b9ad93b6f8e1a978a2f8f1b78c628b96b7e812"},"integrity":{"algorithm":"sha256","contentSha256":"1d5a6102da29eaf8e3fe9721e2619916ed93ae59db4db9eed2706cd2f5160be3"}}